Debiopharm Innovation Fund
Investor profile
Venture capital
Debiopharm Innovation Fund has backed 5 European tech companies across 6 funding rounds between 2020 and 2026, joining rounds totalling €74M. Most active in Healthtech and AI. Data as of 4 Nov 2026.
Deals
6
distinct rounds
Companies
5
backed
Active span
2020–2026
7 yrs
Total round €
€74M
sum of rounds joined
Deals by year
distinct rounds / yearDebiopharm Innovation Fund — deals by year — interactive chart.
Data table
| Debiopharm Innovation Fund — deals by year | |
|---|---|
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 1 |
Top sectors
by dealsDebiopharm Innovation Fund — top sectors — interactive chart.
Data table
| Debiopharm Innovation Fund — top sectors | |
|---|---|
| Healthtech | 6 |
| AI | 1 |
Stages
by dealsDebiopharm Innovation Fund — stages — interactive chart.
Data table
| Debiopharm Innovation Fund — stages | |
|---|---|
| Series A | 5 |
| Series B | 1 |
Countries
by dealsDebiopharm Innovation Fund — countries — interactive chart.
Data table
| Debiopharm Innovation Fund — countries | |
|---|---|
| France | 3 |
| Belgium | 1 |
| Germany | 1 |
| Israel | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Whitelab Genomics | France | 2 | €33M |
| Iktos | France | 1 | €16M |
| Oncomfort | Belgium | 1 | €10M |
| Fosanis | Germany | 1 | €10M |
| Nucleai | Israel | 1 | €5.8M |